tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Myriad Genetics backs FY25 adjusted EPS view (2c)-2c, consensus 1c

Backs FY25 revenue view $818M-$828M, consensus $822.38M. Backs FY25 adjusted EBITDA view $27M-$33M.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1